Findings revealed biological pathways as potential intervention points, and demonstrated in fruit flies potential therapeutic strategies.

The Flagship Pioneering spinout uses permanent bonds to target shallow pockets, drastically expanding the druggable universe for small molecules.

Over the next two years, the planned funding will be allocated to projects that have received some FDA feedback as well as emerging efforts.

Immunotherapy that blocks microglial Fcγ receptors prevents dopaminergic neuron loss in Parkinson’s disease, revealing a potential new strategy.

Under the agreement, SanegeneBio has granted Genentech exclusive worldwide rights to develop and commercialize the undisclosed program.

The two companies plan to expand their collaboration around Sinorda Biomedicine’s potential pipeline, including multiple integrated projects.

Study results indicate that mutation strength may shape both tumor–immune system interactions and immunotherapy response.

Prior seasonal influenza virus immunity did not impair antibody responses or protection conferred by the intranasal H5N1 vaccine.

Cardiff Oncology saw its shares nosedive following the departure of its CEO and CFO, plus questions about some Phase II data for its candidate onvansertib in first-line RAS-mutated metastatic ...

Engineered BiTE molecule draws T cells to eliminate FAP+ modulated smooth muscle cells, reducing plaque burden across mouse atherosclerosis models.

AlphaGenome is a DNA sequence model that advances regulatory variant-effect prediction to understand genome function.

Yeast-based protein expression systems will likely play an important role in vaccine production during future pandemics.